fda safety warning

FDA logs more than 1,700 adverse event reports involving compounded semaglutide and tirzepatide — Photo by Axel Sandoval on P

fda safety warning

Stop Ignoring FDA’s Warning on Compounded Semaglutide

Compounded semaglutide carries a heightened risk of adverse events, and the FDA has issued a safety warning to protect patients. The warning highlights over 1,700 reported incidents and urges immediate action for anyone using these formulations. Medical Disclaimer: This article is for informational purposes only and does not constitute